Raf Souccar Insider Profile
4 Followers
Raf Souccar, Director at Origin Therapeutics Holdings, Inc., holds 2.45M shares in Origin Therapeutics Holdings, Inc. (Ticker: TSE:ROVA), holds 4.51M shares in Aleafia Health (Ticker: ALEAF). Most recently, Raf Souccar Bought ― shares of Origin Therapeutics Holdings, Inc. on Apr 15, 2026 for an estimated value of C$25.42K.
Raf Souccar's Trading History
| ROVAOrigin Therapeutics Holdings, Inc. | Apr 15, 2026 | Director | Informative Buy | 25.42K | C$134.98K | |
| ALEAFAleafia Health | Mar 30, 2020 | ― | Informative Buy | 3.51K | $67.65K |
You May Also Like
Raf Souccar insider profile FAQ
What is the percentage of profitable transactions made by Raf Souccar?
The percentage of profitable transactions made by Raf Souccar is 50%.
What is the average return per transaction made by Raf Souccar?
The average return per transaction made by Raf Souccar is 7.30%.
What stocks does Raf Souccar hold?
Raf Souccar holds: TSE:ROVA, ALEAF stocks.
What was Raf Souccar’s latest transaction?
Raf Souccar’s latest transaction was an Informative Buy of C$25.42K.
What was Raf Souccar's most profitable transaction?
Raf Souccar’s most profitable transaction was an Informative Buy of ALEAF stock on March 30, 2020. The return on the trade was 73.30%.
What is Raf Souccar's role in Origin Therapeutics Holdings, Inc.?
Raf Souccar's role in Origin Therapeutics Holdings, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.